Terms: = Ovarian cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
17 results:
1. Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma.
Zhang Z; Wang J; Wu X; Liu Y; Xi X
J Obstet Gynaecol Res; 2022 Aug; 48(8):2180-2188. PubMed ID: 35778826
[TBL] [Abstract] [Full Text] [Related]
2. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of nomograms for predicting the prognosis of grade 3 endometrial endometrioid adenocarcinoma cancers: a SEER-based study.
Liu X; Zhao J; Sun Z; Wang G
Bioengineered; 2021 Dec; 12(1):1752-1765. PubMed ID: 33975518
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic characteristics and prognosis comparison of the uterine high grade endometrial carcinomas.
Sucu M; Kucukgoz Gulec U; Paydas S; Guzel AB; Kilic Bagir E; Vardar MA
Ginekol Pol; 2021; 92(4):278-283. PubMed ID: 33751504
[TBL] [Abstract] [Full Text] [Related]
5. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
[No Abstract] [Full Text] [Related]
6. Challenges and controversies in the conservative management of uterine and ovarian cancer.
Janda M; McGrath S; Obermair A
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():93-108. PubMed ID: 30243603
[TBL] [Abstract] [Full Text] [Related]
7. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
Wang Q; Wang L; L Y; Ding X; Liu A
J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
[TBL] [Abstract] [Full Text] [Related]
8. Folate Receptor Alpha Expression in Platinum Resistant/Refractory ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Rubinsak LA; Cohen C; Khanna N; Horowitz IR; Hanley KZ
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):567-572. PubMed ID: 27941566
[TBL] [Abstract] [Full Text] [Related]
9. Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial cancers: A National cancer Database Analysis.
McGunigal M; Liu J; Kalir T; Chadha M; Gupta V
Int J Gynecol Cancer; 2017 Jan; 27(1):85-92. PubMed ID: 27759595
[TBL] [Abstract] [Full Text] [Related]
10. Association of the immunohistochemical detection of gamma-glutamyl transferase expression with clinicopathological findings in postmenopausal women with endometrioid adenocarcinoma of the uterus.
Pitynski K; Ozimek T; Galuszka N; Banas T; Milian-Ciesielska K; Pietrus M; Okon K; Mikos M; Juszczyk G; Sinczak-Kuta A; Stoj A
J Physiol Pharmacol; 2016 Jun; 67(3):395-402. PubMed ID: 27512000
[TBL] [Abstract] [Full Text] [Related]
11. A survey on fertility management in young women of reproductive age treated with chemotherapy.
Abe A; Kuwahara A; Iwasa T; Nishimura M; Irahara M
Int J Clin Oncol; 2016 Dec; 21(6):1183-1190. PubMed ID: 27402102
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract] [Full Text] [Related]
13. Deubiquitinases and the new therapeutic opportunities offered to cancer.
Pfoh R; Lacdao IK; Saridakis V
Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
[TBL] [Abstract] [Full Text] [Related]
14. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Kesterson J; Clark K; Monhollen L; Odunsi K; Lele S; Liu S
PLoS One; 2010 Nov; 5(11):e15415. PubMed ID: 21079744
[TBL] [Abstract] [Full Text] [Related]
15. Endometrioid carcinoma of the endometrium with choriocarcinomatous differentiation: a case report and review of the literature.
Akbulut M; Tosun H; Soysal ME; Oztekin O
Arch Gynecol Obstet; 2008 Jul; 278(1):79-84. PubMed ID: 18066564
[TBL] [Abstract] [Full Text] [Related]
16. Cytological features of cervical smears in serous adenocarcinoma of the endometrium.
Todo Y; Minobe S; Okamoto K; Takeda M; Ebina Y; Watari H; Terashima M; Kaneuchi M; Yamamoto R; Sakuragi N
Jpn J Clin Oncol; 2003 Dec; 33(12):636-41. PubMed ID: 14769842
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
Berchuck A; Kamel A; Whitaker R; Kerns B; Olt G; Kinney R; Soper JT; Dodge R; Clarke-Pearson DL; Marks P
Cancer Res; 1990 Jul; 50(13):4087-91. PubMed ID: 1972347
[TBL] [Abstract] [Full Text] [Related]
